|
1
|
Wang C, Liu XQ, Hou JS, Wang JN and Huang
HZ: Molecular mechanisms of chemoresistance in oral cancer. Chin J
Dent Res. 19:25–33. 2016.PubMed/NCBI
|
|
2
|
Zhang P, Zhang Z, Zhou X, Qiu W, Chen F
and Chen W: Identification of genes associated with cisplatin
resistance in human oral squamous cell carcinoma cell line. BMC
Cancer. 6:2242006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang B, Liu M, Tang HK, Ma HB, Wang C,
Chen X and Huang HZ: The expression and significance of MRP1, LRP,
TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. J Oral Pathol
Med. 41:141–148. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olszewski U and Hamilton G: A better
platinum-based anticancer drug yet to come? Anticancer Agents Med
Chem. 10:293–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Donzelli S, Mori F, Biagioni F, Bellissimo
T, Pulito C, Muti P, Strano S and Blandino G: MicroRNAs: Short
non-coding players in cancer chemoresistance. Mol Cell Ther.
2:162014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garofalo M and Croce CM: MicroRNAs as
therapeutic targets in chemoresistance. Drug Resist Updat.
16:47–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu ZW, Zhong LP, Ji T, Zhang P, Chen WT
and Zhang CP: MicroRNAs contribute to the chemoresistance of
cisplatin in tongue squamous cell carcinoma lines. Oral Oncol.
46:317–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren W, Wang X, Gao L, Li S, Yan X, Zhang
J, Huang C, Zhang Y and Zhi K: MiR-21 modulates chemosensitivity of
tongue squamous cell carcinoma cells to cisplatin by targeting
PDCD4. Mol Cell Biochem. 390:253–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li J, Huang H, Sun L, Yang M, Pan C, Chen
W, Wu D, Lin Z, Zeng C, Yao Y, et al: MiR-21 indicates poor
prognosis in tongue squamous cell carcinomas as an apoptosis
inhibitor. Clin Cancer Res. 15:3998–4008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M,
Zhang W, Chen W, Pan C, Liu Q, et al: MiR-200b and miR-15b regulate
chemotherapy-induced epithelial-mesenchymal transition in human
tongue cancer cells by targeting BMI1. Oncogene. 31:432–445. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tatarano S, Chiyomaru T, Kawakami K,
Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama
K, Seki N, et al: miR-218 on the genomic loss region of
chromosome 4p15.31 functions as a tumor suppressor in bladder
cancer. Int J Oncol. 39:13–21. 2011.PubMed/NCBI
|
|
12
|
Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S,
Guo X, Wang B, Gang Y, Zhang Y, et al: MiR-218 inhibits invasion
and metastasis of gastric cancer by targeting the Robo1 receptor.
PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: MiR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Venkataraman S, Birks DK, Balakrishnan I,
Alimova I, Harris PS, Patel PR, Handler MH, Dubuc A, Taylor MD,
Foreman NK, et al: MicroRNA 218 acts as a tumor suppressor by
targeting multiple cancer phenotype-associated genes in
medulloblastoma. J Biol Chem. 288:1918–1928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn
PO, Sathyan P, Imtiyaz HZ, Zhang Z, Davuluri RV, Rao S, et al:
miR-218 opposes a critical RTK-HIF pathway in mesenchymal
glioblastoma. Proc Natl Acad Sci USA. 111:291–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu DW, Cheng YW, Wang J, Chen CY and Lee
H: Paxillin predicts survival and relapse in non-small cell lung
cancer by microRNA-218 targeting. Cancer Res. 70:10392–10401. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu DW, Chuang CY, Lin WL, Sung WW, Cheng
YW and Lee H: Paxillin promotes tumor progression and predicts
survival and relapse in oral cavity squamous cell carcinoma by
microRNA-218 targeting. Carcinogenesis. 35:1823–1829. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie J, Yu F, Li D, Zhu X, Zhang X and Lv
Z: MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in
non-small cell lung cancer by targeting RUNX2. Tumour Biol.
37:1197–1204. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian H, Hou L, Xiong YM, Huang JX, She YJ,
Bi XB and Song XR: miR-218 suppresses tumor growth and enhances the
chemosensitivity of esophageal squamous cell carcinoma to
cisplatin. Oncol Rep. 33:981–989. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zarogoulidis P, Petanidis S, Kioseoglou E,
Domvri K, Anestakis D and Zarogoulidis K: MiR-205 and miR-218
expression is associated with carboplatin chemoresistance and
regulation of apoptosis via Mcl-1 and Survivin in lung cancer
cells. Cell Signal. 27:1576–1588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zanette DL, Rivadavia F, Molfetta GA,
Barbuzano FG, Proto-Siqueira R, Silva-Jr WA, Falcão RP and Zago MA:
miRNA expression profiles in chronic lymphocytic and acute
lymphocytic leukemia. Braz J Med Biol Res. 40:1435–1440. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng Z, Zhang L, Zhou J, Zhou S, Li L, Guo
X, Feng G, Ma Z, Huang W and Huang F: mir-218-2 promotes
glioblastomas growth, invasion and drug resistance by targeting
CDC27. Oncotarget. 8:6304–6318. 2017.PubMed/NCBI
|
|
25
|
Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang
W, Jafferji M, Gordon JA, Li Z, Croce CM, van Wijnen AJ, Stein JL,
et al: miR-218 directs a Wnt signaling circuit to promote
differentiation of osteoblasts and osteomimicry of metastatic
cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Su X, Bai H, Zhao J, Duan J, An T,
Zhuo M, Wang Z, Wu M, Li Z, et al: Identification of plasma
microRNA profiles for primary resistance to EGFR-TKIs in advanced
non-small cell lung cancer (NSCLC) patients with EGFR activating
mutation. J Hematol Oncol. 8:1272015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wlodarchak N and Xing Y: PP2A as a master
regulator of the cell cycle. Crit Rev Biochem Mol Biol. 51:162–184.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kumar A, Pandurangan AK, Lu F, Fyrst H,
Zhang M, Byun HS, Bittman R and Saba JD: Chemopreventive
sphingadienes downregulate Wnt signaling via a PP2A/Akt/GSK3β
pathway in colon cancer. Carcinogenesis. 33:1726–1735. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mitra A, Menezes ME, Pannell LK, Mulekar
MS, Honkanen RE, Shevde LA and Samant RS: DNAJB6 chaperones PP2A
mediated dephosphorylation of GSK3β to downregulate β-catenin
transcription target, osteopontin. Oncogene. 31:4472–4483. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu X, Wang C, Chen Z, Jin Y, Wang Y,
Kolokythas A, Dai Y and Zhou X: MicroRNA-138 suppresses
epithelial-mesenchymal transition in squamous cell carcinoma cell
lines. Biochem J. 440:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gosepath EM, Eckstein N, Hamacher A,
Servan K, von Jonquieres G, Lage H, Györffy B, Royer HD and Kassack
MU: Acquired cisplatin resistance in the head-neck cancer cell line
Cal27 is associated with decreased DKK1 expression and can
partially be reversed by overexpression of DKK1. Int J Cancer.
123:2013–2019. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu M, Wang J, Huang H, Hou J, Zhang B and
Wang A: miR-181a-Twist1 pathway in the chemoresistance of tongue
squamous cell carcinoma. Biochem Biophys Res Commun. 441:364–370.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou X, Ren Y, Liu A, Jin R, Jiang Q,
Huang Y, Kong L, Wang X and Zhang L: WP1066 sensitizes oral
squamous cell carcinoma cells to cisplatin by targeting
STAT3/miR-21 axis. Sci Rep. 4:74612014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peng F, Zhang H, Du Y and Tan P: miR-23a
promotes cisplatin chemoresistance and protects against
cisplatin-induced apoptosis in tongue squamous cell carcinoma cells
through Twist. Oncol Rep. 33:942–950. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kinoshita T, Hanazawa T, Nohata N, Kikkawa
N, Enokida H, Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto
Y, et al: Tumor suppressive microRNA-218 inhibits cancer cell
migration and invasion through targeting laminin-332 in head and
neck squamous cell carcinoma. Oncotarget. 3:1386–1400. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peng SC, Liao CT, Peng CH, Cheng AJ, Chen
SJ, Huang CG, Hsieh WP and Yen TC: MicroRNAs MiR-218, MiR-125b, and
Let-7g predict prognosis in patients with oral cavity squamous cell
carcinoma. PLoS One. 9:e1024032014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jamali Z, Aminabadi Asl N, Attaran R,
Pournagiazar F, Oskouei Ghertasi S and Ahmadpour F: MicroRNAs as
prognostic molecular signatures in human head and neck squamous
cell carcinoma: A systematic review and meta-analysis. Oral Oncol.
51:321–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shiah SG, Hsiao JR, Chang WM, Chen YW, Jin
YT, Wong TY, Huang JS, Tsai ST, Hsu YM, Chou ST, et al:
Downregulated miR329 and miR410 promote the proliferation and
invasion of oral squamous cell carcinoma by targeting Wnt-7b.
Cancer Res. 74:7560–7572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kawakita A, Yanamoto S, Yamada S, Naruse
T, Takahashi H, Kawasaki G and Umeda M: MicroRNA-21 promotes oral
cancer invasion via the Wnt/β-catenin pathway by targeting DKK2.
Pathol Oncol Res. 20:253–261. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dickinson RE, Dallol A, Bieche I, Krex D,
Morton D, Maher ER and Latif F: Epigenetic inactivation of
SLIT3 and SLIT1 genes in human cancers. Br J Cancer.
91:2071–2078. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Narayan G, Goparaju C, Arias-Pulido H,
Kaufmann AM, Schneider A, Dürst M, Mansukhani M, Pothuri B and
Murty VV: Promoter hypermethylation-mediated inactivation of
multiple Slit-Robo pathway genes in cervical cancer progression.
Mol Cancer. 5:162006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Roberti A, La Sala D and Cinti C: Multiple
genetic and epigenetic interacting mechanisms contribute to
clonally selection of drug-resistant tumors: Current views and new
therapeutic prospective. J Cell Physiol. 207:571–581. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Iwai S, Yonekawa A, Harada C, Hamada M,
Katagiri W, Nakazawa M and Yura Y: Involvement of the Wnt-β-catenin
pathway in invasion and migration of oral squamous carcinoma cells.
Int J Oncol. 37:1095–1103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang WB, Zhong WJ and Wang L: A
signal-amplification circuit between miR-218 and Wnt/β-catenin
signal promotes human adipose tissue-derived stem cells osteogenic
differentiation. Bone. 58:59–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
